Abstract
We aim to determine the temporal trends of incidence, prevalence, and death of aortic stenosis (AS, I35.0) in an East Asian population. Data for 3773 patients who were newly diagnosed with AS from 2006 through 2017 were extracted from the National Health Insurance Service in Korea. The age-standardized incidence rate, prevalence rate, and death rate, survival rate (SR), and death risk of AS were calculated. Overall, the mean (standard deviation) age of AS patients was 69.9 (15.3) years [66.2 (15.7) years for men and 72.7 (14.4) years for women (P=0.007)], and the proportion of men was 42.7%. The proportion of AS patients ≥60years old was 80% (71.8% in men and 86% in women, P<0.001). The proportion of patients who died of AS was 36.4% during the period from 2006 through 2017. The most common causes of death were disease of the circulatory system. The age-standardized incidence, prevalence, and death rates in 2017 were 0.85, 2.79, and 0.58 persons per 100000 persons, respectively. The 10year SR was 49.2%. The higher adjusted HRs [95% CI] for AS were observed in 70- to 79-year-old people (9.08 [1.27, 64.7], P=0.027), in individuals 80years of age or older (22.7 [3.18, 161.9], P=0.001), in men (1.46 [1.31, 1.63], P<0.001), among the middle socioeconomic group (1.19 [1.03, 1.37], P=0.016), among the lower income levels (1.32 [1.17, 1.49], P<0.001), in those with myocardial infarction (1.57 [1.16, 2.13], P=0.003), with heart failure (1.63 [1.44, 1.85], P<0.001), with ischaemic stroke (3.26 [1.20, 8.85], P=0.015), with haemorrhagic stroke (2.51 [1.94, 3.25], P=0.02), with chronic kidney disease (2.51 [1.94, 3.25], P<0.001), and with malignant neoplasm (2.33 [1.64, 3.31], P<0.001). The proportion of AS at age ≥60years was 80%. For AS, the age-standardized incidence rates were steady, prevalence rates increased, and death rates decreased by year over a decade. The 10year SR of AS was about 50%. The most common cause of death in AS was disease of the circulatory system. Given the progressively higher incidence of AS with age continued efforts are required to increase awareness regarding AS-related symptoms and potential complications in aged people.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.